EUVIMEDEUVIMED entdecken
Crossref

Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling

Tetsuro Marunouchi, Kasumi Matsumura, Eriko Fuji, Akihiro Iwamoto, Kouichi Tanonaka

Pharmacology · 2024

DOI: 10.1159/000534933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, 2024. Verfasst von Tetsuro Marunouchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Pharmacology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan. Hauptthemen laut MEDLINE: Heart Failure, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Heart Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is still no effective treatment for heart failure with preserved left ventricular ejection fraction (HFpEF), and therapies to improve prognosis are urgently needed. Clinical studies in patients with HFpEF have shown that statins and HMG-CoA reductase inhibitors may reduce their mortality rate. However, the mechanisms underlying the effects of statins on HFpEF remain unknown. In the present study, we examined whether simvastatin administration inhibits the development of cardiac fibrosis in HFpEF model mice. We further examined the contribution of the Smad and mitogen-activated protein (MAP) kinase pathways to the transforming growth factor-β (TGF-β) signaling pathway in the development of HFpEF.

Methods

HFpEF animals were prepared by feeding C57BL/6 N mice a high-fat diet and providing water containing N[w]-nitro-l-arginine methyl ester hydrochloride (l-NAME) for 15 weeks. Simvastatin (30 mg/kg/day) or vehicle was administered orally daily during the experimental period. Cardiac function was measured by echocardiography, and cardiac fibrosis was evaluated by Masson’s trichrome staining. Changes in the TGF-β signaling proteins in myocardial tissue were examined by Western blotting.

Results

A high-fat diet and l-NAME solution load induced cardiac diastolic dysfunction with cardiac fibrosis. Simvastatin treatment markedly attenuated cardiac fibrosis and reduced cardiac diastolic dysfunction. In addition, simvastatin prevented the increase in phosphorylation levels of Smad (Smad2 and Smad3) and MAPK (c-Raf, Erk1/2) pathway proteins downstream of the TGF-β receptor in cardiac tissue.

Conclusions

Our present study demonstrated that simvastatin attenuated diastolic dysfunction by reducing cardiac fibrosis in HFpEF hearts. Furthermore, our findings suggest that the mechanisms by which simvastatin attenuates HFpEF development involve, at least in part, inhibition of the TGF-β signaling pathway, which is activated in the HFpEF heart.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHydroxymethylglutaryl-CoA Reductase InhibitorsHeart DiseasesHumansMiceAnimalsSimvastatinStroke VolumeTransforming Growth Factor betaVentricular Function, LeftMice, Inbred C57BLSignal TransductionFibrosis

Stichwörter der Autor:innen

Cardiac fibrosisHeart failure with preserved ejection fractionSimvastatinTGF-β signaling

Substanzen

SimvastatinTransforming Growth Factor betaHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Molecular and Cellular Pharmacology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.

Zitieren

APA

Marunouchi, T., Matsumura, K., Fuji, E., Iwamoto, A., & Tanonaka, K. (2024). Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling. Pharmacology. https://doi.org/10.1159/000534933

Vancouver

Marunouchi T, Matsumura K, Fuji E, Iwamoto A, Tanonaka K. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling. Pharmacology. 2024. doi:10.1159/000534933

BibTeX
@article{Marunouchi2024,
  author = {Marunouchi, Tetsuro and Matsumura, Kasumi and Fuji, Eriko and Iwamoto, Akihiro and Tanonaka, Kouichi},
  title = {Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling},
  journal = {Pharmacology},
  year = {2024},
  doi = {10.1159/000534933}
}
Kostenlos starten →